All articles by Staff Writer

Staff Writer

Unique panel of bone turnover marker tests

Bone turnover markers (BTM) support therapy monitoring in osteoporosis and aid in the diagnosis of certain metabolic bone disorders. Euroimmun (part of Revvity) offers a comprehensive panel of BTM tests, which covers all markers recommended for monitoring osteoporosis therapy, including in patients with kidney disease.

Our VIASURE Monkeypox Virus Real Time PCR kit is among the diagnostic tests highlighted by the WHO

The World Health Organization (WHO) has recently approved the inclusion of the VIASURE Monkeypox Virus Real Time PCR Detection Kit in the list of in vitro diagnostic devices authorized for use in public health emergency situations (EUL).

Beckman Coulter Life Sciences and HSE•AG Partner to Revolutionize Nucleic Acid Quantification and Purification Through Liquid Handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, is redefining nucleic acid quantification through a strategic collaboration with Hombrechtikon Systems Engineering•AG (HSE•AG), a Swiss provider of customized automation and engineering solutions for the life sciences and diagnostics sectors.

GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025 

Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)—the world’s leading cause of death, responsible for an estimated 20.5 million deaths globally. [i]

GE HealthCare unveils Vivid Pioneer, its most advanced AI-powered cardiovascular ultrasound system, designed to enhance speed and image quality for improved diagnostic confidence and workflow efficiency  

GE HealthCare (Nasdaq: GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet, completely redesigned to support clinicians with extraordinary imaging in 2D, 4D and color flow, streamlined workflow, and enhanced diagnostic confidence. The ultrasound system recently received CE Mark and U.S. FDA 510(k) clearance. 

Randox Unveils Revolutionary Evidence RABTA

Randox is proud to announce the launch of its pioneering Evidence RABTA (Random Access Biochip Technology Analyser), setting a new standard in laboratory diagnostics. A new addition to the Evidence series range of analysers, this state-of-the-art analyser combines advanced Biochip Array Technology with exceptional efficiency, designed to meet the demanding needs of modern laboratories.

Are You Going to WOCNext?

NATROX® Wound Care will be in Orlando, FL for the WOCNext Conference June 1-3, 2025. Don’t miss this exciting opportunity to learn more about Continuous Topical Oxygen Therapy (cTOT) with NATROX® O₂.

Microbix & Aurevia Introduce Novel EQA Scheme

Pilot Program for Qualifying Clinical Labs to Diagnose Bacterial Vaginosis

QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample preparation instruments during 2025 and 2026 to expand and strengthen its portfolio for automated sample preparation.